These antibody studies clearly demonstrated that ab15311 and HPA006539 target Glut3 and Glu14, respectively, and inhibit both transporters, impacting GBM cells grown on Gal to a greater extent than on Glc (Figure 3E). Here, SLC2A3 is linked to glioblastoma.